Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Neil Harris Cohen currently holds 33,000 shares of Chemomab Therapeutics Ltd. (CMMB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neil Harris Cohen has been a net buyer of CMMB stock. They have purchased $147.4K and sold $11.3K worth of shares.
Neil Harris Cohen's most recent insider trade was on Aug 28, 2026, when they sold 1,000 shares at $2.80 per share.
Neil Harris Cohen serves as Executive at Chemomab Therapeutics Ltd. (CMMB). They have executed 16 insider transactions totaling $158.7K over their tenure at the company.
Neil Harris Cohen holds the position of Executive at Chemomab Therapeutics Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Neil Harris Cohen has shown a buying trading pattern, with $147.4K in total purchases and $11.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Neil Harris Cohen was on Mar 16, 2021, when they purchased $100.0K worth of CMMB shares. This transaction involved 2,409 shares at $41.51 per share.
Neil Harris Cohen currently owns 33,000 shares of Chemomab Therapeutics Ltd. (CMMB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Neil Harris Cohen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Neil Harris Cohen has 16 Form 4 filings on record as an insider at Chemomab Therapeutics Ltd..
Set alerts for Neil Harris Cohen and 40,000+ other insiders.